Single or Divided Administration of Cisplatin Can Induce Inflammation and Oxidative Stress in Male Sprague-Dawley Rats
Abstract
BACKGROUND: Cisplatin is one of the most potent chemotherapy drugs to treat various types of cancer, however the use of cisplatin has some the adverse effect, such as the increase of oxidative stress and inflammation by malondialdehyde (MDA) and nuclear factor kappa B (NF-kB) activation. Since the dosing of cisplatin is critical, we observed the effect of single and multiple doses of cisplatin injection on rats’ inflammation and oxidative stress level.
METHODS: Total of 27 male Sprague-Dawley rats were divided into 9 sub-groups, each consisted of 3 rats. The baseline sub-group received no treatments; Group 1 (sub-group 1.1, 1.2, 1.3, and 1.4) were administered one single dose of 5 mg/kg BW/intravenously (i.v) of cisplatin; and Group 2 (sub-group 2.1, 2.2, 2.3, and 2.4) were given 0.2 mg/kg BW/i.v of cisplatin twice a week for two months. Rats were observed for their body weight, NF-kB, and MDA level based on the assigned group.
RESULTS: Body weight loss was observed in the 1st week after treatment for Group 1, and 7th week for Group 2. Group 1 and Group 2 showed increasing level of NF-kB and MDA since the 1st observation, which was the 1st week and 5th week, respectively. NF-kB and MDA and levels were also significantly increasing in both groups for every week of observation (p<0.05).
CONCLUSION: Cisplatin injection either in single or divided dose can induce inflammation and oxidative stress thus decrease the body weight. However, dividing cisplatin in smaller dose can delay the inflammation effect on subjects.
KEYWORDS: cisplatin dose, MDA, NF-kB, body weight, inflammation, oxidative stress
Full Text:
PDFReferences
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin. 2021;71(3): 209-9, CrossRef.
World Health Organization/WHO. World health statistics 2020: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2020, article.
Aldossary SA. Review on pharmacology of cisplatin: clinical use, toxicity and mechanism of resistance of cisplatin. Biochem Pharmacol. 2019; 12(1): 7-15, CrossRef.
Mei Y. Review of the oxicological mechanism of anticancer drug Cisplatin. AIP Conf Proc. 2021; 2350: 020010, CrossRef.
Karimi F, Kassaei S, Baradaran A, Ashrafi F, Talebi A, Lak Z, et al. Dextrose hydration may promote cisplatin-induced nephrotoxicity in rats: gender-related difference. Indones Biomed J. 2019; 11(2): 136-44, CrossRef.
Perse M, Veceric-Haler Z. Cisplatin-induced rodent model of kidney injury: characteristics and challenges. Biomed Res Int. 2018; 2018: 1462802, CrossRef.
Sandra F. Targeting ameloblatoma into apoptosis. Indones Biomed J. 2018; 10(1): 35-9, CrossRef.
Widowati W, Jasaputra DK, Sumitro SB, Widodo MA, Afifah E, Rizal R, et al. Direct and indirect effect of TNFα and IFNγ toward apoptosis in breast cancer cells. Mol Cell Biomed Sci. 2018; 2 (2): 60-9, CrossRef.
Mirzaei S, Hushmandi K, Zabolian A, Saleki H, Torabi SMR, Ranjbar A, et al. Elucidating role of reactive oxygen species (ROS) in cisplatin chemotherapy: a focus on molecular pathways and possible therapeutic strategies. Molecules. 2021; 26(2382): 1-37, CrossRef.
Marulo R, Werner E, Degtyareva N, Moore B, Altavilla G, Ramaligam SS, et al. Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions. PLoS One. 2013; 8(11): e.81162, CrossRef.
Stewart JH, Tran TL, Levi N, Tsai WS, Schrump DS, Nguyen DM. The essential role of the mitochondria and reactive oxygen species in cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma. J Surg Res. 2007; 141(1): 120-31, CrossRef.
Soni H, Kaminskib D, Gangarajub R, Adebiyia A. Cisplatin-induced oxidative stress stimulates renal Fas ligand shedding. Ren Fail. 2018; 40(1): 314-22, CrossRef.
Siddiq AM, Ilmiawan MI, Handini M. Protective effect of combination commercial black seed oil (Nigella sativa) and honey against cisplatin-induced hepatotoxicity in eats. Muhammadiyah Med J. 2020; 1(2): 1-6, CrossRef.
Kandemir FM, Benzer F, Yildirim NC, Ozdemir N. Compensatory effects of curcumin on cisplatin-induced toxicity in rabbit testis. J Med Plants Res. 2011; 5(3): 455-61, article.
Ray S, Roy K, Sengupta C. Cisplatin-induced lipid peroxidation and its inhibition with ascorbic acid. Indian J Pharm Sci. 2006; 68(2): 199-204, CrossRef.
Kan Y, Liu J, and Li F. High expression of nuclear transcription factor-κB is associated with cisplatin resistance and prognosis for ovarian cancer. Cancer Manag Res. 2020; 12: 8241-52, CrossRef.
Rahaju P, Kintono RA, Wahyudiono AD, Satria A, Sandra F. Immunohistochemical expression of EGFR, NF-kB and cyclin D1 in sinonasal inverted papilloma and squamous cell carcinoma. Indones Biomed J. 2020; 12(3): 239-44, CrossRef.
Oiso S, Ikeda R, Nakamura K, Takeda Y, Akiyama S, Kariyazono H. Involvement of NF-κB activation in the cisplatin resistance of human epidermoid carcinoma KCP-4 cells. Oncol Rep. 2012; 28: 27-32, CrossRef.
Mabuchi S, Ohmichi M, Nishio Y, Hayasaka T, Kimura A, Ohta T, et al. Inhibition of NFkB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J Biol Chem. 2004; 279(22): 23477-85, CrossRef.
Ilbey YO, Ozbek E, Cekmen M, Simsek A, Octunctemur A, Somay A. Protective effect of curcumin in cisplatin-induced oxidative injury in rat testis: mitogen-activated protein kinase and nuclear factor-kappa B signaling pathways. Hum Reprod. 2009; 24(7): 1717-25, CrossRef.
Almeida LO, Abrahao AC, Rosselli-Murai LK, Giudice FS, Zagni C, Leopoldino AM, et al. NF κB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC). FEBS Open Bio. 2014; 4: 96-104, CrossRef.
Qi X, Xu W, Xie J, Wang Y, Han S, Wei Z, et al. Metformin sensitizes the response of oral squamous cell carcinoma to cisplatin treatment through inhibition of NF-κB/HIF-1α signal axis. Sci Rep. 2016; 6(35788): 1-11, CrossRef.
Li X, Guo S, Xiong XK, Peng BY, Huang JM, Chen MF, et al. Combination of quercetin and cisplatin enhances apoptosis in OSCC cells by downregulating xIAP through the NF-κB pathway. J Cancer. 2019; 10(19): 4509-21, CrossRef.
Hayati N, Panjaitan C, Sandra F. Microbiome in oral squamous cell carcinoma: mechanisms and signaling pathways. Mol Cell Biomed Sci. 2020; 4(2): 52-60, CrossRef.
Abdellatief SA, Galal AA, Farouk SM, Abdel-Daim MM. Ameliorative effect of parsley oil on cisplatin-induced hepato-cardiotoxicity: A biochemical, histopathological, and immunohistochemical study. Biomed Pharmacother. 2017; 86: 482-491, CrossRef.
Ahmed HA, Ghobara MM. Histological study of the effect of cisplatin on the liver of adult male albino rat. Int J Acad Sci Res. 2013; 1(1): 22-33.
Wuhan Fine Biotech. Fine Test Rat NF-κB (Nuclear Factor Kappa B) ELISA Kit. Wuhan: Wuhan Fine Biotech; [n.y.], article.
Cell Biolabs. Product Manual: OxiSelect™ TBARS Assay Kit (MDA Quantitation). San Diego: Cell Biolabs; [n.y.], article.
Agu ST, Ezihe CO, Itodo PF, and Abu HA. Lophira lanceolata protects testicular and spermatological damages induced by cisplatin in male Wistar rats. Clin Phytoscience. 2020; 6(87): 1-7, CrossRef.
Afsar T, Razak S, Aldisi D, Shabbir M, Almajwal A, Al Kheraif AA, et al. Acacia hydaspica R. Parker ethyl-acetate extract abrogates cisplatin-induced nephrotoxicity by targeting ROS and inflammatory cytokines. Sci Rep. 2021; 11(17248): 1-16, CrossRef.
Sirago G, Conte E, Fracasso F, Cormio A, Fehrentz JA, Martinez J, et al. Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia. Sci. Rep. 2017; 7(1): 1-14, CrossRef.
Moreira-Pais A, Ferreira R, da Costa RG. Platinum-induced muscle wasting in cancer chemotherapy: Mechanism and potential targets for theurapeutic intervention. Life Sci. 2018; 208: 1-9, CrossRef.
Sahu BD, Kalvala AK, Koneru M, Kumar JM, Kuncha M, Rachamalla SS, et al. Ameliorative effect of fisetin on cisplatin-induced nephrotoxicity in rats via modulation of NF-κB activation and antioxidant defence. PloS One. 2014; 9(9): e105070, CrossRef.
Kumar P, Kadakol A, Shasthrula P, Mundhe NA, Jamdade VS, Barua CC, et al. Curcumin as an adjuvant to breast cancer treatment. Anti Cancer Agents Med Chem. 2015; 15(5): 647-56, CrossRef.
Thakur KK, Bolshette NB, Trandafir C, Jamdade VS, Istrate A, Gogoi R, et al. Role of toll-like receptors in multiple myeloma and recent advances. Exp Hematol. 2014; 43(3): 158-67, CrossRef.
Jamdade VS, Mundhe NA, Kumar P, Tadla V, Lahkar M. Raloxifene inhibits NF-kB pathway and potentiates anti-tumour activity of cisplatin with simultaneous reduction in its nephrotoxictiy. Pathol Oncol Res. 2016; 22(1): 145-53, CrossRef.
Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017; 2(e17023): 1-9, CrossRef.
Sari SDP, Maknun LU, Louisa M, Estuningyta A, Soetikno V. Effect of nanocurcumin against cisplatin induced-nephrotoxicity in rats. Adv Sci Lett. 2017; 23(7): 6823-7, CrossRef.
El-shafaei A, Abdelmaksoud R, Elshorbagy A, Zahran N, Elabd R. Protective effect of melatonin versus montelukast in cisplatin induced seminiferous tubule damage in rats. Andrologia. 2018; 50(9): e13077, CrossRef.
DOI: https://doi.org/10.18585/inabj.v14i2.1745
Copyright (c) 2022 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
